Nasal Compression Device for Nosebleed

Next Level Urgent Care, Houston, TX
NosebleedNasal Compression Device - Device
All Sexes

Study Summary

This trial will compare a nasal compression device to manual compression to stop nosebleeds. Participants will evaluate their experience to see which works best.

Treatment Effectiveness

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: Checked at 10 min intervals for a total of 3 intervals (30 min).

Checked at 10 min intervals for a total of 3 intervals (30 min).
- Change over time from full epistaxis to cessation.

Trial Safety

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

2 Treatment Groups

Standard of Care
1 of 2
Nasal Compression Device
1 of 2

Active Control

Experimental Treatment

40 Total Participants · 2 Treatment Groups

Primary Treatment: Nasal Compression Device · No Placebo Group · N/A

Nasal Compression Device
Experimental Group · 1 Intervention: Nasal Compression Device · Intervention Types: Device
Standard of Care
ActiveComparator Group · 1 Intervention: Routine Care · Intervention Types: DiagnosticTest

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: checked at 10 min intervals for a total of 3 intervals (30 min).

Who is running the clinical trial?

NasaClipLead Sponsor
Emergency Medical Innovations, LLCUNKNOWN

Eligibility Criteria

Age 18+ · All Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are presenting with bleeding from the front of your nose that is caused by a vein and can be stopped using external pressure.

Who else is applying?

What state do they live in?
What site did they apply to?
Next Level Urgent Care100.0%
What portion of applicants met pre-screening criteria?
Met criteria100.0%

Frequently Asked Questions

Is this research endeavor actively seeking to expand its participants?

"According to, this medical experimentation is currently recruiting patients and has been doing so since March 1st 2023 (most recently edited on the 15th of that same month)." - Anonymous Online Contributor

Unverified Answer

What is the current selection quota for this trial?

"Affirmative. According to, this trial is currently enrolling patients that meet their requirements. Initially posted on March 1st 2023 with the most recent update occurring on March 15th 2023, 40 individuals are being sought by a single medical centre." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.